A Toxic Combination
Zeineh examines the case of 73-year-old man with a known history of chronic obstructive pulmonary disease. He was promptly intubated by the emergency department physicians, placed on mechanical ventilation, and given intravenous levofloxacin and corticosteroids. He was transferred to the medical int...
Gespeichert in:
Veröffentlicht in: | The American journal of medicine 2010-08, Vol.123 (8), p.707-708 |
---|---|
1. Verfasser: | |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 708 |
---|---|
container_issue | 8 |
container_start_page | 707 |
container_title | The American journal of medicine |
container_volume | 123 |
creator | Zeineh, Nabil S., MD |
description | Zeineh examines the case of 73-year-old man with a known history of chronic obstructive pulmonary disease. He was promptly intubated by the emergency department physicians, placed on mechanical ventilation, and given intravenous levofloxacin and corticosteroids. He was transferred to the medical intensive care unit for management. An electrocardiogram (ECG) taken at admission showed signs of left ventricular hypertrophy and a QT interval corrected for heart rate of 450 msec. The patient's ECG changes and arrhythmia were multifactorial in etiology. Specifically, the diagnosis was levofloxacin-induced QT prolongation in the context of severe left ventricular dysfunction and chronic amiodarone therapy. The administration of levofloxacin in combination with amiodarone therapy precipitated the patient's ECG changes and arrhythmia. |
doi_str_mv | 10.1016/j.amjmed.2010.03.002 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_746433168</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0002934310002275</els_id><sourcerecordid>2117271691</sourcerecordid><originalsourceid>FETCH-LOGICAL-c473t-91543378c9bc274d5456c26131f3e81c2648aa72c322840733131da91a246ce3</originalsourceid><addsrcrecordid>eNqFUU1LAzEQDaLYWj15FSmCx12TTD52L0IpfkHBg72HNJuFrN3dmmzF_nuzbKvgxVMmM2_ezHuD0BXBKcFE3FWprqvaFinFMYUhxZgeoTHhnCeSCHqMxjimkhwYjNBZCFX84pyLUzSiWEgsKYzR5Wy6bL-cmc7beuUa3bm2OUcnpV4He7F_J2j5-LCcPyeL16eX-WyRGCahS3LCGYDMTL4yVLKCMy4MFQRICTYjMWSZ1pIaoDRjWALEUqFzoikTxsIE3Qy0G99-bG3oVNVufRMnKslEpCYiiyA2gIxvQ_C2VBvvau13imDV-6AqNfigeh8UBhVFx7brPfd21dcOTQfhEXC7B-hg9Lr0ujEu_OIAZ5LHJSbofsDZaMSns14F42xjbOG8NZ0qWvffJn8JzNo1Ls58tzsbfiQTFajC6q2_WX8y0gdUcvgGCxWM4A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>746433168</pqid></control><display><type>article</type><title>A Toxic Combination</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Zeineh, Nabil S., MD</creator><creatorcontrib>Zeineh, Nabil S., MD</creatorcontrib><description>Zeineh examines the case of 73-year-old man with a known history of chronic obstructive pulmonary disease. He was promptly intubated by the emergency department physicians, placed on mechanical ventilation, and given intravenous levofloxacin and corticosteroids. He was transferred to the medical intensive care unit for management. An electrocardiogram (ECG) taken at admission showed signs of left ventricular hypertrophy and a QT interval corrected for heart rate of 450 msec. The patient's ECG changes and arrhythmia were multifactorial in etiology. Specifically, the diagnosis was levofloxacin-induced QT prolongation in the context of severe left ventricular dysfunction and chronic amiodarone therapy. The administration of levofloxacin in combination with amiodarone therapy precipitated the patient's ECG changes and arrhythmia.</description><identifier>ISSN: 0002-9343</identifier><identifier>EISSN: 1555-7162</identifier><identifier>DOI: 10.1016/j.amjmed.2010.03.002</identifier><identifier>PMID: 20670723</identifier><identifier>CODEN: AJMEAZ</identifier><language>eng</language><publisher>New York, NY: Elsevier Inc</publisher><subject>Aged ; Amiodarone - therapeutic use ; Anti-Arrhythmia Agents - therapeutic use ; Anti-Bacterial Agents - adverse effects ; Biological and medical sciences ; Cardiac arrhythmia ; Chronic obstructive pulmonary disease ; Drug Therapy, Combination - adverse effects ; Electrocardiography ; General aspects ; Heart Conduction System - drug effects ; Humans ; Internal Medicine ; Male ; Medical sciences ; Myocardial Ischemia - complications ; Ofloxacin - adverse effects ; Pulmonary Disease, Chronic Obstructive - complications ; Torsades de Pointes - complications</subject><ispartof>The American journal of medicine, 2010-08, Vol.123 (8), p.707-708</ispartof><rights>Elsevier Inc.</rights><rights>2010 Elsevier Inc.</rights><rights>2015 INIST-CNRS</rights><rights>Copyright Elsevier Sequoia S.A. Aug 2010</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c473t-91543378c9bc274d5456c26131f3e81c2648aa72c322840733131da91a246ce3</citedby><cites>FETCH-LOGICAL-c473t-91543378c9bc274d5456c26131f3e81c2648aa72c322840733131da91a246ce3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.amjmed.2010.03.002$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=23087564$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20670723$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Zeineh, Nabil S., MD</creatorcontrib><title>A Toxic Combination</title><title>The American journal of medicine</title><addtitle>Am J Med</addtitle><description>Zeineh examines the case of 73-year-old man with a known history of chronic obstructive pulmonary disease. He was promptly intubated by the emergency department physicians, placed on mechanical ventilation, and given intravenous levofloxacin and corticosteroids. He was transferred to the medical intensive care unit for management. An electrocardiogram (ECG) taken at admission showed signs of left ventricular hypertrophy and a QT interval corrected for heart rate of 450 msec. The patient's ECG changes and arrhythmia were multifactorial in etiology. Specifically, the diagnosis was levofloxacin-induced QT prolongation in the context of severe left ventricular dysfunction and chronic amiodarone therapy. The administration of levofloxacin in combination with amiodarone therapy precipitated the patient's ECG changes and arrhythmia.</description><subject>Aged</subject><subject>Amiodarone - therapeutic use</subject><subject>Anti-Arrhythmia Agents - therapeutic use</subject><subject>Anti-Bacterial Agents - adverse effects</subject><subject>Biological and medical sciences</subject><subject>Cardiac arrhythmia</subject><subject>Chronic obstructive pulmonary disease</subject><subject>Drug Therapy, Combination - adverse effects</subject><subject>Electrocardiography</subject><subject>General aspects</subject><subject>Heart Conduction System - drug effects</subject><subject>Humans</subject><subject>Internal Medicine</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Myocardial Ischemia - complications</subject><subject>Ofloxacin - adverse effects</subject><subject>Pulmonary Disease, Chronic Obstructive - complications</subject><subject>Torsades de Pointes - complications</subject><issn>0002-9343</issn><issn>1555-7162</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFUU1LAzEQDaLYWj15FSmCx12TTD52L0IpfkHBg72HNJuFrN3dmmzF_nuzbKvgxVMmM2_ezHuD0BXBKcFE3FWprqvaFinFMYUhxZgeoTHhnCeSCHqMxjimkhwYjNBZCFX84pyLUzSiWEgsKYzR5Wy6bL-cmc7beuUa3bm2OUcnpV4He7F_J2j5-LCcPyeL16eX-WyRGCahS3LCGYDMTL4yVLKCMy4MFQRICTYjMWSZ1pIaoDRjWALEUqFzoikTxsIE3Qy0G99-bG3oVNVufRMnKslEpCYiiyA2gIxvQ_C2VBvvau13imDV-6AqNfigeh8UBhVFx7brPfd21dcOTQfhEXC7B-hg9Lr0ujEu_OIAZ5LHJSbofsDZaMSns14F42xjbOG8NZ0qWvffJn8JzNo1Ls58tzsbfiQTFajC6q2_WX8y0gdUcvgGCxWM4A</recordid><startdate>20100801</startdate><enddate>20100801</enddate><creator>Zeineh, Nabil S., MD</creator><general>Elsevier Inc</general><general>Elsevier</general><general>Elsevier Sequoia S.A</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>7TK</scope><scope>7TO</scope><scope>7TS</scope><scope>7U9</scope><scope>H94</scope><scope>K9.</scope></search><sort><creationdate>20100801</creationdate><title>A Toxic Combination</title><author>Zeineh, Nabil S., MD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c473t-91543378c9bc274d5456c26131f3e81c2648aa72c322840733131da91a246ce3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Aged</topic><topic>Amiodarone - therapeutic use</topic><topic>Anti-Arrhythmia Agents - therapeutic use</topic><topic>Anti-Bacterial Agents - adverse effects</topic><topic>Biological and medical sciences</topic><topic>Cardiac arrhythmia</topic><topic>Chronic obstructive pulmonary disease</topic><topic>Drug Therapy, Combination - adverse effects</topic><topic>Electrocardiography</topic><topic>General aspects</topic><topic>Heart Conduction System - drug effects</topic><topic>Humans</topic><topic>Internal Medicine</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Myocardial Ischemia - complications</topic><topic>Ofloxacin - adverse effects</topic><topic>Pulmonary Disease, Chronic Obstructive - complications</topic><topic>Torsades de Pointes - complications</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Zeineh, Nabil S., MD</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Physical Education Index</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><jtitle>The American journal of medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zeineh, Nabil S., MD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A Toxic Combination</atitle><jtitle>The American journal of medicine</jtitle><addtitle>Am J Med</addtitle><date>2010-08-01</date><risdate>2010</risdate><volume>123</volume><issue>8</issue><spage>707</spage><epage>708</epage><pages>707-708</pages><issn>0002-9343</issn><eissn>1555-7162</eissn><coden>AJMEAZ</coden><abstract>Zeineh examines the case of 73-year-old man with a known history of chronic obstructive pulmonary disease. He was promptly intubated by the emergency department physicians, placed on mechanical ventilation, and given intravenous levofloxacin and corticosteroids. He was transferred to the medical intensive care unit for management. An electrocardiogram (ECG) taken at admission showed signs of left ventricular hypertrophy and a QT interval corrected for heart rate of 450 msec. The patient's ECG changes and arrhythmia were multifactorial in etiology. Specifically, the diagnosis was levofloxacin-induced QT prolongation in the context of severe left ventricular dysfunction and chronic amiodarone therapy. The administration of levofloxacin in combination with amiodarone therapy precipitated the patient's ECG changes and arrhythmia.</abstract><cop>New York, NY</cop><pub>Elsevier Inc</pub><pmid>20670723</pmid><doi>10.1016/j.amjmed.2010.03.002</doi><tpages>2</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0002-9343 |
ispartof | The American journal of medicine, 2010-08, Vol.123 (8), p.707-708 |
issn | 0002-9343 1555-7162 |
language | eng |
recordid | cdi_proquest_journals_746433168 |
source | MEDLINE; Access via ScienceDirect (Elsevier) |
subjects | Aged Amiodarone - therapeutic use Anti-Arrhythmia Agents - therapeutic use Anti-Bacterial Agents - adverse effects Biological and medical sciences Cardiac arrhythmia Chronic obstructive pulmonary disease Drug Therapy, Combination - adverse effects Electrocardiography General aspects Heart Conduction System - drug effects Humans Internal Medicine Male Medical sciences Myocardial Ischemia - complications Ofloxacin - adverse effects Pulmonary Disease, Chronic Obstructive - complications Torsades de Pointes - complications |
title | A Toxic Combination |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-20T07%3A46%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20Toxic%20Combination&rft.jtitle=The%20American%20journal%20of%20medicine&rft.au=Zeineh,%20Nabil%20S.,%20MD&rft.date=2010-08-01&rft.volume=123&rft.issue=8&rft.spage=707&rft.epage=708&rft.pages=707-708&rft.issn=0002-9343&rft.eissn=1555-7162&rft.coden=AJMEAZ&rft_id=info:doi/10.1016/j.amjmed.2010.03.002&rft_dat=%3Cproquest_cross%3E2117271691%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=746433168&rft_id=info:pmid/20670723&rft_els_id=S0002934310002275&rfr_iscdi=true |